Stemtech (OTCQB:STEK), a global leader in stem cell nutrition, proudly unveils its latest advancements with key leadership appointments and the highly anticipated launch of StemPets™. Committed to revolutionizing health solutions for both individuals and pets, Stemtech continues to push innovation in the wellness sector.
Set to launch in early Q2 of 2025, StemPets™ marks Stemtech’s entry into the rapidly growing pet healthcare market, projected to surpass $303 billion by 2027.
John W. Meyer, President & COO of Stemtech, expressed enthusiasm for this new product line:
“We are excited to bring the power of stem cell nutrition to pets, offering a breakthrough solution for pet owners. StemPets™ is a game-changer in pet care, uniquely positioning us to capture market growth with science-backed products.”
To support its expansion strategy, Stemtech welcomes new executives to drive global growth:
Alejandro Carrillo, Vice President of Global Operations – Oversees manufacturing, inventory management, and expansion strategies.
Srilakshmi Vadlapatla, Global Accounts Manager & Future CFO – Leads financial strategy, leveraging extensive international finance expertise.
Manuel Ramirez Garcia, Director of Global Sales & Field Development – Heads global sales initiatives and market development, bringing over 20 years of industry experience.
John W. Meyer further commented:
“We are thrilled to have Srilakshmi and Manuel join our leadership team, and Alex in his new role. Their expertise in finance, global sales, and operations will drive Stemtech’s continued growth and innovation.”
Additionally, Stemtech extends its appreciation to outgoing CFO James S. “Jay” Cardwell for his invaluable contributions to the company.
Stemtech has long been a pioneer in stem cell nutrition, boasting a diverse portfolio of natural health solutions, including:
StemRelease3™
StemFlo™ Advanced
OraStem® Toothpaste
Cellect One® Shield
With the launch of StemPets™ in April 2025, Stemtech further solidifies its position at the forefront of innovation in the health and wellness industry.
Charles S. Arnold, Chairman & CEO, emphasized the company’s exciting growth trajectory:
“We are entering an exciting chapter of growth. The launch of StemPets™ and our strengthened leadership team position us to lead the pet healthcare market. We look forward to transforming lives and helping families enjoy healthier, happier lives with their pets.”
For nearly two decades, Stemtech has been a trailblazer in natural, plant-based health solutions, leading advancements in the wellness, anti-aging, and longevity sectors. With industry forecasts predicting unprecedented growth, Stemtech remains committed to quality and scientific innovation, ensuring a healthier future for all by naturally slowing the aging process.
